Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Sign me in automatically next time
Scrip   
Pipeline watch
02 October 2009

This week’s Pipeline Watch records two first approvals of new products, both in the US. Theravance/Astellas’s Vibativ (telavancin) has got the US FDA nod for complicated skin and skin structure infections (cSSSI) caused by Gram-positive bacteria in adults. Astellas, which has the rights to...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36